These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5565429)

  • 21. Increase of mexiletine plasma levels due to delayed hepatic metabolism in patients with chronic liver disease.
    Nitsch J; Steinbeck G; Lüderitz B
    Eur Heart J; 1983 Nov; 4(11):810-4. PubMed ID: 6653593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Main factors of variations in lidocaine pharmacokinetics].
    Bruguerolle B; Valli M; Jadot G; Bouyard P
    Therapie; 1983; 38(1):27-38. PubMed ID: 6346570
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacokinetics of drugs in single and multiple organ failure].
    Schwilden H
    Ann Fr Anesth Reanim; 1990; 9(3):265-8. PubMed ID: 2372152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasma lidocaine concentrations during epidural anesthesia--a comparison between patients with normal liver functions and those with abnormal functions].
    Miyamoto M; Hayano Y; Noguchi T; Oda S; Taniguchi K; Honda N; Ebihara A
    Masui; 1988 Jun; 37(6):696-700. PubMed ID: 3216464
    [No Abstract]   [Full Text] [Related]  

  • 25. Clofibrate disposition in renal failure and acute and chronic liver disease.
    Gugler R; Kürten JW; Jensen CJ; Klehr U; Hartlapp J
    Eur J Clin Pharmacol; 1979 Jun; 15(5):341-7. PubMed ID: 456406
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the absorption, distribution and metabolism of labelled prilocaine and lidocaine in some animal species.
    Akerman B; Aström A; Ross S; Telc A
    Acta Pharmacol Toxicol (Copenh); 1966; 24(4):389-403. PubMed ID: 6013121
    [No Abstract]   [Full Text] [Related]  

  • 27. Thiamine and cocarboxylase concentration in heart, liver and kidney, of patients with heart failure.
    WOHL MG; BRODY M; SHUMAN CR; TURNER R; BRODY J
    J Clin Invest; 1954 Nov; 33(11):1580-6. PubMed ID: 13211813
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics in patients with cardiac failure.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1976; 1(6):389-405. PubMed ID: 799548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition of azapropazone in chronic renal and hepatic failure.
    Breuing KH; Gilfrich HJ; Meinertz T; Wiegand UW; Jähnchen E
    Eur J Clin Pharmacol; 1981; 20(2):147-55. PubMed ID: 7262176
    [No Abstract]   [Full Text] [Related]  

  • 31. Alteration of the kinetics of tocainide in combined hepatic and renal insufficiency.
    Endell W; Oltmanns D; Pottage T
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):589-90. PubMed ID: 6420626
    [No Abstract]   [Full Text] [Related]  

  • 32. [State of the cardiovascular system in chronic renal insufficiency].
    Sumarokov AV; Mikhaĭlov AA; Moiseev VS
    Kardiologiia; 1969 Aug; 9(8):128-35. PubMed ID: 4906927
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques.
    Alderman EL; Kerber RE; Harrison DC
    Am J Cardiol; 1974 Sep; 34(3):342-9. PubMed ID: 4851926
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs.
    Boyes RN; Adams HJ; Duce BR
    J Pharmacol Exp Ther; 1970 Jul; 174(1):1-8. PubMed ID: 5424701
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lidocaine in arrhythmias. Practical success and side effects].
    Rasmussen K
    Tidsskr Nor Laegeforen; 1969 Mar; 89(6):416. PubMed ID: 5792122
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic clearance of human growth hormone in patients with hepatic and renal failure, and in the isolated perfused pig liver.
    Cameron DP; Burger HG; Catt KJ; Gordon E; Watts JM
    Metabolism; 1972 Oct; 21(10):895-904. PubMed ID: 5071956
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of congestive heart failure on blood vessels of lidocaine and its active monodeethylated metabolite.
    Halkin H; Meffin P; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1975 Jun; 17(6):669-76. PubMed ID: 1139858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of lidocaine after intramuscular injection in patients with acute myocardial infarction (author's transl)].
    Oltmanns D; Siegers CP
    Z Kardiol; 1979 Mar; 68(3):131-6. PubMed ID: 442753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of lidocaine by continuous infusion.
    Bassan MM; Weinstein SR; Mandel WJ
    Am Heart J; 1974 Mar; 87(3):302-3. PubMed ID: 4812367
    [No Abstract]   [Full Text] [Related]  

  • 40. Elementary pharmacokinetics in clinical practice. 5: The effect of pathological condition on pharmacokinetics.
    Paxton JW
    N Z Med J; 1982 Feb; 95(702):116-8. PubMed ID: 6952117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.